LightPath Technologies, Inc. — Form 10-Q Summary
Reporting period: Quarter and six months ended December 31, 2022 (fiscal 2023 Q2 and first half). Comparative figures are for the periods ended December 31, 2021. The financial statements are unaudited.
Business context
LightPath designs and manufactures optical components and assemblies, including precision molded optics (PMO), infrared products and specialty products. Operations span the United States, China and Latvia. Its strategy emphasizes moving toward customer-designed optical solutions and longer-term supply relationships.
Key financial results
| Metric | Three months ended Dec. 31, 2022 | Six months ended Dec. 31, 2022 |
|---|---|---|
| Revenue | $8.47 million, down 8% year over year | $15.84 million, down 14% |
| Gross profit / margin | $3.22 million / 38%, versus $2.80 million / 30% | $5.46 million / 34%, versus $5.97 million / 33% |
| Operating loss | $556,000, versus $980,000 | $1.79 million, versus $1.39 million |
| Net loss / diluted loss per share | $694,000 / $0.03, versus $1.06 million / $0.04 | $2.07 million / $0.08, versus $1.69 million / $0.06 |
| EBITDA (non-GAAP) | $207,000, versus a $41,000 loss | $185,000 loss, versus $413,000 positive |
| Cash used in operating activities | $752,000 for the six-month period, versus $157,000 |
Quarterly gross margin improved mainly because of product mix and improved infrared manufacturing costs. First-half gross profit declined with revenue, although the reported margin percentage edged up. Higher quarterly gross profit helped reduce the quarterly net loss; for the half year, lower revenue and gross profit contributed to a larger net loss.
Balance sheet, cash and debt
- At December 31, cash and cash equivalents were $3.79 million, down from $5.51 million at June 30, 2022; working capital was approximately $9.6 million. More than half of cash was held by foreign subsidiaries.
- Total liabilities were $18.77 million. Loans payable were approximately $3.85 million, including about $3.6 million on the BankUnited term loan and $305,000 on an equipment loan. Operating lease liabilities totaled approximately $9.85 million.
- First-half cash use reflected, among other items, lower accounts payable and accrued liabilities, payment of China-related severance, and final payment of deferred payroll taxes. Capital expenditures were $412,000, compared with $1.32 million in the prior-year period.
- On February 7, 2023, after quarter-end, BankUnited extended the term-loan maturity to December 31, 2024, revised payment terms and waived certain financial covenants through December 31, 2023. The amendment required a $1 million principal reduction by February 28, 2023; the filing does not establish whether that payment had been made by the filing date.
- On January 17, 2023, the company completed an offering of 9,090,910 shares at $1.10 per share, receiving approximately $9.2 million net. This provides liquidity but dilutes existing shareholders. Shares outstanding were 36,662,524 as of February 6, 2023.
Material changes and operating developments
- Quarterly revenue fell primarily because infrared product shipments against a large annual contract were completed in Q2; shipments under its renewed contract were expected to start in Q3. The renewal was 20% larger than the prior contract.
- For the first half, infrared revenue decreased 23% and PMO revenue decreased 6%; specialty revenue rose 27%, supported by collimator assemblies and a charge for in-process materials after a customer order cancellation.
- Backlog was approximately $29.4 million at December 31, up 34% year over year and 66% from fiscal year-end. Management cited large customer orders, including a $4 million European supply agreement expected to begin in fiscal Q4 and run about 12–18 months. In Q3, the company also reported qualification for a military program and an initial order valued at $2.5 million. Backlog and order timing do not guarantee revenue recognition.
Outlook, risks and unusual items
- Management said the January equity raise reduced the expected need for additional equity capital in the foreseeable future, but identified lower sales, higher input and labor costs, and unrealized production improvements as factors that could require more funding. It provided no numerical revenue or earnings guidance.
- Management expects weak Chinese demand to continue to weigh on fiscal 2023 revenue in that region, citing economic conditions, COVID-19 effects and prior sales disruption during the transition of China subsidiary management. It said production and supply to other subsidiaries had not been materially affected.
- Other uncertainties include COVID-19 and travel restrictions, the Russia-Ukraine conflict, supplier availability, inflation and interest rates, and the company’s ability to convert inventory and sustain profitable sales growth.
- Cash held in China may be subject to repatriation conditions; LPOIZ had approximately $3.9 million of earnings available for repatriation, while LPOI had none. The company also has substantial lease commitments and estimated it would fund approximately $2.5 million of Orlando facility improvements beyond a $2.4 million landlord allowance, mostly in the second half of fiscal 2023.
- China employee-related legal proceedings continued; approximately $485,000 of disputed severance was paid to the court in October 2022. Management expected minimal additional legal and consulting costs. It stated that other legal matters were not expected to materially affect financial position or results.
Most important facts for investors to verify
- Whether shipments under the renewed infrared contract began as expected in fiscal Q3, and how much revenue and cash collection it produces.
- Conversion, timing and customer concentration of the $29.4 million backlog, including the $4 million supply agreement and $2.5 million military-program order.
- Completion and funding of the $1 million BankUnited principal reduction, compliance with amended payment terms, and future interest and exit-fee obligations.
- Cash burn, availability of foreign-held cash, and whether the equity proceeds and operating cash flow are sufficient to fund facility improvements and ongoing operations.
- Whether continued weakness in China, lower unit shipments and cost pressures affect margins and the company’s path to profitability.